Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going

Miguel Muniz, Charles L. Loprinzi, Jacob J. Orme, Regina M. Koch, Ahmed Mahmoud, Adam M. Kase, Irbaz B Riaz, Jack R. Andrews, Matthew Thorpe, Geoffrey B. Johnson, A. Tuba Kendi, Eugene D. Kwon, Jones T. Nauseef, Alicia K. Morgans, Oliver Sartor, Daniel S. Childs